These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17114453)

  • 1. A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.
    Hillebrands JL; Whalen B; Visser JT; Koning J; Bishop KD; Leif J; Rozing J; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2006 Dec; 177(11):7820-32. PubMed ID: 17114453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats.
    Chung YH; Jun HS; Son M; Bao M; Bae HY; Kang Y; Yoon JW
    J Immunol; 2000 Sep; 165(5):2866-76. PubMed ID: 10946320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.
    Holm TL; Lundsgaard D; Markholst H
    Scand J Immunol; 2006 Jul; 64(1):17-29. PubMed ID: 16784487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations.
    Zipris D; Hillebrands JL; Welsh RM; Rozing J; Xie JX; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Apr; 170(7):3592-602. PubMed ID: 12646622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.
    Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ
    Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.
    Stephens LA; Mason D
    J Immunol; 2000 Sep; 165(6):3105-10. PubMed ID: 10975823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes.
    Caicedo RA; Li N; Des Robert C; Scumpia PO; Hubsher CP; Wasserfall CH; Schatz DA; Atkinson MA; Neu J
    Pediatr Res; 2008 Mar; 63(3):303-7. PubMed ID: 18091354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3.
    Lundsgaard D; Holm TL; Hornum L; Markholst H
    Diabetes; 2005 Apr; 54(4):1040-7. PubMed ID: 15793242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of the CD4⁺Foxp3⁺CD25(-/low) regulatory T-cell subpopulation in type 1 diabetes mellitus.
    Zóka A; Barna G; Somogyi A; Műzes G; Oláh Á; Al-Aissa Z; Hadarits O; Kiss K; Firneisz G
    Autoimmunity; 2015; 48(5):289-97. PubMed ID: 25523632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
    Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
    J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
    Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
    J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells.
    Dahlberg PE; Schartner JM; Timmel A; Seroogy CM
    Clin Exp Immunol; 2007 Aug; 149(2):226-34. PubMed ID: 17490400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 Effect on Quantitative Changes of CD4
    Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
    Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.